Ventripoint Diagnostics Announces U.S. FDA 510(k) Clearance for VMS+(TM) 4.0 Automated Radiological Image Processing Software/System

Stock Information for VentriPoint Diagnostics Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About VentriPoint Diagnostics Ltd.

THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis
Healthcare AI Exits Pilot Phase, Enters Production Deployment
Ventripoint Unveils a Global Model for A.I.-Enhanced Heart Care through Partnership with the Nisga'a Valley Health Authority
From Hype to P&L: Hospitals Now Buying AI That Pays
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
UPDATE -- The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
Ventripoint Diagnostics Announces Appointment of David Swetlow as Chief Financial Officer
CEO.CA's Inside the Boardroom: Ventripoint Diagnostics: We Made Ultrasound as Good as MRI - Now Here's How We Scale It

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.